News / Stock

Australia: Genetics The Science Of The Future. According To Alphie The Stock Is Solid.

May 22, 2020 - 14:14 GMT+0000

The company was founded in 2001. Genetic Signatures (GSS.AX), listed at the Sydney stock exchange in Australian Dollars, is a molecular diagnostics company. It is engaged in the research and commercialization of identifying individual genetic signature to identify diseases and disabilities, and the sale of associated products into diagnostic and research market place. It is focused on the development and commercialization of its platform technology, 3Base. According to an internal report, the company’s revenue in 2019 totaled 4.86 million Australian Dollars. The company’s stock price has been relatively constant since late March and can now be found at 2.03 Australian…

Register to continue reading for free